Data from the proposed amino acid sequence for ORF-4 (Britton et al., 1988) were used to synthesize three oligopeptides (produced by Dr T. Doel, AFRC Institute for Animal Health, Pirbright Laboratory, U.K.) as shown in Fig. 2 . These corresponded to Thr 37 to Lys 55, peptide 12A/86, Gly 19 to Lys 55, peptide 12B/86, and Gly 19 to Lys 36, peptide 1/87. As can be seen, peptides 1/87 and 12A/86 formed the N and C termini of peptide 12B/86 respectively. The peptides were coupled to glutaraldehyde-activated keyhole limpet haemocyanin (KLH) (Calbiochem) for 5 h at 20 °C in 0.15 M-NaCI, 0-06 M-phosphate buffer pH 7.8 at the rate of I mg peptide/1 mg KLH, emulsified in Freund's complete adjuvant and inoculated into pairs of rabbits, 1 ml intramuscularly and four subcutaneous injections of 0-25 ml. Four weeks later, the rabbits were reinoculated with peptide-KLH conjugates emulsified in Freund's incomplete adjuvant, 0-25 ml intramuscular plus 0-25 ml subcutaneous and serum samples were obtained 4 weeks later.
TGEV-infected cells were labelled with [35S]methionine as above, and lysed at 10 h postinfection with RIPA buffer ( 1~ sodium deoxycholate, 1 ~ Triton X-100, 0.1 ~ SDS, 1 mM-PMSF and 1 mM-methionine in phosphate-buffered saline pH 7-2). Cell lysates were centrifuged at 15000g for 30 min in a microcentrifuge to remove virus particles and aggregates. The supernatants were adsorbed with formalinized Staphylococcus aureus cells (Immunoprecipitin; BRL-Gibco) for 20 min at 20 °C, centrifuged to remove the bacteria and aliquots were mixed with 1/100 dilutions of sera from rabbits before and after immunization with peptides or with 1/1000 dilutions of mouse anti-TGEV serum. After 2 h at 20 °C, S. aureus were added for a further 1 h and the adsorbed immune precipitates were sedimented at 10000g for 1 min and washed by four rounds of resuspension and sedimentation in RIPA buffer. The final pellets were resuspended in 50 ~tl of PAGE sample buffer, held at 100 °C for 2 min then sedimented at 10000g for 2 min. The supernatants were analysed by PAGE with 12 to 20~ exponential gradient gels. Fig. 1 (b) shows the immune precipitates generated by preimmune rabbit serum (lane 1), rabbit anti-peptide 12A/86 (lane 2) and 12B/86 (lane 3) or mouse anti-TGEV serum (lane 4). Specific antibodies could not be detected in serum from rabbits inoculated with peptide 1/87. A small amount of the host cell antigen was precipitated by preimmune rabbit serum whereas mouse anti-TGEV serum detected the virion proteins as well as small amounts of other proteins. By comparison with prestained Mr standards in an adjacent lane (not shown), the native 14K protein was the only product specifically precipitated by the anti-12B/86 serum. The same protein was also precipitated by anti-12A/86, but to a much lesser extent and requiring longer exposure for it to be visualized (not shown).
To determine the intracellular location of the 14K protein, infected and uninfected cells were fixed with acetone at 2 h intervals during a 10 h incubation period and examined by immune fluorescence with 1/100 dilutions of serum samples from rabbits before and after immunization with peptide 12B/86. The first evidence of specific immune fluorescence in the TGEV-infected cells was seen 5 to 7 h after infection as a faint fluorescent stippling in the nucleus (Fig. 3 b) . By 8 to 10 h after infection, this was intensified to a marked granular antigen fluorescence in the nuclei of most infected cells (Fig. 3c) and was not seen in the uninfected cells nor with preimmune serum. Following 10 h, the infected cells underwent a marked cytopathology and the fluorescence was less obvious due to degradation of the nucleus. Duplicate cells, stained with Giemsa stain to show their morphology, showed the extent of the nuclear vacuolation in the infected cells in the last 1 to 2 h of the infection (Fig. 3 e) .
Translation of the experimentally determined sequence of ORF-4 would result in a polypeptide with several interesting features, as previously described (Britton et al., 1988) i The polypeptide has 78 amino acids with an Mr of 9068. The difference in size between that predicted and the 14K observed by PAGE could be accounted for by the fact that the protein is very hydrophobic, containing 36 ~o leucine. Reduction and carboxymethylation of the protein by iodoacetamide resulted in a band with an electrophoretic mobility corresponding to approximately 11K (not shown). Whether this represents the monomeric form of a 14K dimer is difficult to assess but it seems more likely to reflect a change in secondary structure induced by the treatment. Attempts to demonstrate the presence of covalently linked carbohydrate in the 14K protein have failed but the possibility cannot be ruled out that the 9K primary translation product is subsequently glycosylated. There is a potential N-linked glycosylation site at Asn 30 and potential O-linkage sites at the two serine and four threonine residues throughout the molecule. The eventual localization of the molecule in the nucleus may suggest Nacetylglucosamine linkage to the serine or threonine, as recently reviewed for nuclear proteins by Hart et al. (1988) , but it seems unlikely that this mechanism, even if it were occurring, would account for an increase in apparent Mr of the magnitude seen.
The nuclear location of the 14K protein at the end of the viral growth cycle is consistent with the cell association previously reported by Wesley and coworkers (1987) and the hydrophobic nature of the protein. Information about the nature of nuclear signals on proteins is insufficient to be sure whether such a signal is present on the molecule although there is some evidence of a 'leucine zipper' motif (Landschultz et al., 1988) . This theory postulates that the presence of a heptad repeat of leucine residues may result in an or-helical conformation which can interdigitate with a similar molecule to form a dimer. The leucine zipper motif is a characteristic property of some DNA-binding proteins and the leucine residues at positions 21, 28 and 35 in ORF-4 form a potential zipper motif. Following the detection of the protein in the nucleus, there was a marked disruption of the nuclear structure but whether this was caused by the 14K product, another viral protein or was a consequence of general cytopathology cannot be ascertained at present. There has been some debate on the requirement for the cell nucleus in coronavirus replication. Evans & Simpson (1980) demonstrated that avian infectious bronchitis virus replication was blocked in cells from which the nucleus had been removed or inactivated and suggested a requirement for transcriptional factors similar to those essential for influenza virus. Two other groups working with murine hepatitis virus, however, showed that the virus grew efficiently in enucleated cells (Brayton et al., 1981; Wilhelmsen et al., 1981) . TGEV will replicate in the presence of actinomycin D, as originally demonstrated by Clarke (1968) , indicating that nuclear transcription is not required. The role of the TGEV 14K protein in the nucleus, therefore, may be to overcome host resistance in the animal rather than to be essential for the replication and maturation of progeny virus in cell culture and the gene product therefore warrants further investigation.
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